Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) shares saw unusually-high trading volume on Monday . Approximately 760,466 shares were traded during trading, a decline of 9% from the previous session’s volume of 836,102 shares.The stock last traded at $60.03 and had previously closed at $63.28.
Analyst Ratings Changes
Several equities research analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft raised their price objective on Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Cantor Fitzgerald restated a “neutral” rating and set a $90.00 target price on shares of Acadia Healthcare in a research report on Monday, August 19th. Barclays decreased their target price on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a research note on Monday. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $94.00 price target on shares of Acadia Healthcare in a research note on Friday, September 20th. One analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $86.67.
Get Our Latest Analysis on Acadia Healthcare
Acadia Healthcare Trading Down 4.5 %
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last posted its earnings results on Wednesday, July 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.87 by $0.04. The business had revenue of $796.00 million for the quarter, compared to analysts’ expectations of $784.38 million. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. During the same period in the prior year, the company posted $0.92 EPS. The business’s revenue for the quarter was up 8.8% compared to the same quarter last year. On average, equities research analysts predict that Acadia Healthcare Company, Inc. will post 3.51 EPS for the current fiscal year.
Institutional Trading of Acadia Healthcare
A number of institutional investors have recently made changes to their positions in the stock. Blue Trust Inc. raised its holdings in Acadia Healthcare by 86.1% in the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after purchasing an additional 248 shares in the last quarter. Mather Group LLC. purchased a new stake in shares of Acadia Healthcare during the 1st quarter valued at about $48,000. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of Acadia Healthcare during the second quarter valued at approximately $59,000. nVerses Capital LLC purchased a new stake in Acadia Healthcare in the second quarter worth approximately $95,000. Finally, Innealta Capital LLC purchased a new stake in Acadia Healthcare during the 2nd quarter valued at $164,000.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Read More
- Five stocks we like better than Acadia Healthcare
- What is the Shanghai Stock Exchange Composite Index?
- TJX Stock: A Buying Opportunity Before the Holiday Rush
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge
- CD Calculator: Certificate of Deposit Calculator
- Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.